HAL vs INM · P/E 9.3, $19.05B cap vs rev $4.9M
Halliburton Company (HAL) versus InMed Pharmaceuticals Inc (INM) — a side-by-side from cached financials, not a winner call.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
InMed Pharmaceuticals Inc (INM) is a drug manufacturers - specialty & generic company listed on US.
HAL does not have a complete income-statement cache yet.
Latest reported INM revenue for 2025-06-30 was $4.9M. Net income was -$8.2M. Revenue was up 7.5% from 2024-06-30 to 2025-06-30. INM currently screens at market cap $5.2M.
HAL currently screens at market cap $19.05B and trailing P/E 9.3. INM currently screens at market cap $5.2M.
Not investment advice. Open the HAL and INM stock pages for the full models.
Not investment advice.